Application 212156
- Type
- NDA
- Sponsor
- PAR STERILE PRODUCTS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MICAFUNGIN | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | 50MG | No | No |
| 002 | MICAFUNGIN | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212156-001 | MICAFUNGIN | MICAFUNGIN SODIUM | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD | 2021-06-16 | |
| N212156-002 | MICAFUNGIN | MICAFUNGIN SODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD | 2021-06-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD | 2021-06-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD | 2021-06-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212156-001 | MICAFUNGIN | EQ 50MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212156-002 | MICAFUNGIN | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2021-06-16 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Micafungin | MICAFUNGIN | Hisun Pharmaceuticals USA, Inc. | 230fcff4-ad4b-ea25-e063-6394a90a1fab | 2026-04-14 | Warnings, Adverse reactions | Micafungin |
| Micafungin | MICAFUNGIN | Zydus Lifesciences Limited | 72bc5dd6-6052-4483-9b13-afdeaaa8cc69 | 2025-12-22 | Micafungin | |
| Micafungin | MICAFUNGIN SODIUM | Sagent Pharmaceuticals | 33e579c1-b315-44cb-a690-e2dd2cdf44ee | 2025-11-08 | Warnings, Adverse reactions | Micafungin MICAFUNGIN SODIUM |
| Micafungin | MICAFUNGIN SODIUM | Fresenius Kabi USA, LLC | dc5241be-4b85-4f04-8553-9819603373b8 | 2025-10-23 | Warnings, Adverse reactions | Micafungin MICAFUNGIN SODIUM |
| MICAFUNGIN | MICAFUNGIN | Glenmark Pharmaceuticals Inc., USA | 31e74606-bccd-4276-bb20-a1933ce4ca25 | 2025-09-09 | Warnings, Adverse reactions | MICAFUNGIN |
| Micafungin | MICAFUNGIN SODIUM | Hikma Pharmaceuticals USA Inc. | 8ba6f80c-05f0-4d75-930c-c8458db2e1c1 | 2025-08-22 | Warnings, Adverse reactions | Micafungin MICAFUNGIN SODIUM |
| Micafungin | MICAFUNGIN | Zydus Pharmaceuticals USA Inc. | 29f17423-5787-47d0-a83b-bbdc0198fbfa | 2025-01-20 | Warnings, Adverse reactions | Micafungin |
| Micafungin | MICAFUNGIN SODIUM | Fresenius Kabi USA, LLC | f8198836-4011-40b9-af25-466ae08727f8 | 2024-10-09 | Warnings, Adverse reactions | Micafungin MICAFUNGIN SODIUM |
| Micafungin | MICAFUNGIN SODIUM | Meitheal Pharmaceuticals Inc. | 579ff093-0359-4e0e-a6ea-2b6adac80bf0 | 2024-08-13 | Warnings, Adverse reactions | Micafungin MICAFUNGIN SODIUM |
| MICAFUNGIN | MICAFUNGIN | Qilu Pharmaceutical Co., Ltd | 653f8c75-b5b8-41ea-8b33-5baad1680bda | 2024-05-10 | Warnings, Adverse reactions | MICAFUNGIN |
| MICAFUNGIN | MICAFUNGIN | Biocon Pharma Inc. | 5a74d7e9-1ca2-37dd-cbcf-d7fde1f5a606 | 2023-10-04 | Warnings, Adverse reactions | MICAFUNGIN |
| Mycamine | MICAFUNGIN SODIUM | Astellas Pharma US, Inc. | a064c4a7-25ec-4a2c-afc2-703491a4a38b | 2020-07-23 | Warnings, Adverse reactions | MICAFUNGIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42023-229 | Micafungin | Micafungin | Par Pharmaceutical, Inc. | NDA | Current |
| 42023-229 | Micafungin | Micafungin | Par Pharmaceutical, Inc. | NDA | Current |
| 42023-230 | Micafungin | Micafungin | Par Pharmaceutical, Inc. | NDA | Current |
| 42023-230 | Micafungin | Micafungin | Par Pharmaceutical, Inc. | NDA | Current |